Global Reach Magnamed is recognized in over 40 countries, indicating established international demand and potential for expanding sales through distributors or direct exports to new markets with comparable critical care needs.

Critical Care Focus With a dedicated portfolio of pulmonary ventilators and a test analyzer, Magnamed targets high-value hospital segments such as ICUs and NICUs, creating upsell opportunities for advanced ventilatory support, service contracts, and calibration/maintenance.

Growth & Capacity Rapid growth history and a dedicated manufacturing facility in Cotia suggest scalability potential; sales plays could emphasize turnkey procurement, local manufacturing support, and rapid delivery to respond to hospital demand or surge capacity.

Strategic Funding As part of the Criatec fund with prior rounds, Magnamed may be receptive to equipment modernization projects, joint ventures, or co-investment opportunities for hospital networks seeking innovative, high-tech medical devices.

Tech Stack Fit Utilizing CAD, SOLIDWORKS, Azure and cloud-based tools signals maturity in product design and integration readiness; there is potential to offer compliance, validation services, remote monitoring software enhancements, and data analytics integrations for customers.